Chris Kaster has been actively investing in healthcare since 2000. He specializes in healthcare investments in the medical device, health technology, diagnostics, and services sectors. During his investment career, Chris served on over 40 boards of directors. Chris has personally overseen the deployment of $950 million in equity capital in healthcare companies. Before the development of Cadence Healthcare Ventures, Chris was the Founder and CEO of Alhambra Medical, Inc. and 33 BioMedical, Inc. These companies were established in partnership with Boston Scientific and raised $10 million of financing to develop products in the peripheral vascular and interventional oncology space. Before this partnership, Chris was recruited to establish Boston Scientific Ventures; this was a fully discretionary fund, which Chris led from January 2012 to September 2019.

About Our Founder

During this period, Chris led financings in 45 companies from seed to commercial stage opportunities. In addition, Chris also deployed $780 million. Previously, Chris was a General Partner at Medventure Associates from 2003 to 2012. Furthermore, Chris was previously a Senior Research Analyst with WR Hambrecht + Co., covering the medical device and diagnostic sectors. Chris previously came from Piper Sandler, previously known as Piper Jaffray.